Anirvan Ghosh is Chief Executive Officer of Unity Biotechnology, Inc.. Currently has a direct ownership of 76,325 shares of UBX, which is worth approximately $109,908. The most recent transaction as insider was on Mar 31, 2022, when has been sold 14,472 shares (Common Stock, $0.0001 par value) at a price of $1.14 per share, resulting in proceeds of $16,498. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.3K
0.79% 3M change
7.17% 12M change
Total Value Held $109,908

Anirvan Ghosh Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2022
SELL
Payment of exercise price or tax liability
$16,498 $1.14 p/Share
14,472 Reduced 1.37%
1,039,923 Common Stock, $0.0001 ...
Mar 14 2022
SELL
Payment of exercise price or tax liability
$8,159 $0.88 p/Share
9,272 Reduced 0.87%
1,054,395 Common Stock, $0.0001 ...
Feb 09 2022
BUY
Grant, award, or other acquisition
-
141,667 Added 11.75%
1,063,667 Common Stock, $0.0001 ...
Jun 24 2021
BUY
Grant, award, or other acquisition
-
72,000 Added 7.24%
922,000 Common Stock, $0.0001 ...
Jan 29 2021
BUY
Grant, award, or other acquisition
-
250,000 Added 22.73%
850,000 Common Stock, $0.0001 ...
AG

Anirvan Ghosh

Chief Executive Officer
South San Francisco, CA

Track Institutional and Insider Activities on UBX

Follow Unity Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UBX shares.

Notify only if

Insider Trading

Get notified when an Unity Biotechnology, Inc. insider buys or sells UBX shares.

Notify only if

News

Receive news related to Unity Biotechnology, Inc.

Track Activities on UBX